BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 21749302)

  • 1. Current evidence on the safety profile of NSAIDs for the treatment of PDA.
    Romagnoli C; Bersani I; Rubortone SA; Lacerenza S; De Carolis MP
    J Matern Fetal Neonatal Med; 2011 Nov; 24 Suppl 3():10-3. PubMed ID: 21749302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic closure of the ductus arteriosus: benefits and limitations.
    Mercanti I; Boubred F; Simeoni U
    J Matern Fetal Neonatal Med; 2009; 22 Suppl 3():14-20. PubMed ID: 19925358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral ibuprofen and indomethacin for treatment of patent ductus arteriosus in premature infants: a randomized trial at Ramathibodi Hospital.
    Supapannachart S; Limrungsikul A; Khowsathit P
    J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1252-8. PubMed ID: 12549803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ibuprofen: alternative treatment for patent ductus arteriosus.
    Flores M
    Neonatal Netw; 2003; 22(2):27-31. PubMed ID: 12696723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonsteroidal anti-inflammatory drugs (NSAIDs) in the newborn - which ones?
    Aranda JV; Beharry KD; Valencia GB
    J Matern Fetal Neonatal Med; 2009; 22 Suppl 3():21-2. PubMed ID: 19925359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral ibuprofen in early curative closure of patent ductus arteriosus in very premature infants.
    Cherif A; Jabnoun S; Khrouf N
    Am J Perinatol; 2007 Jun; 24(6):339-45. PubMed ID: 17564958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New therapeutic strategies for the treatment of patent ductus arteriosus in preterm infants.
    Dani C
    J Matern Fetal Neonatal Med; 2011 Nov; 24 Suppl 3():5-6. PubMed ID: 21815877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal safety of Non Steroidal Anti Inflammatory Drugs (NSAIDs) in the pharmacologic treatment of patent ductus arteriosus.
    Fanos V; Marcialis MA; Bassareo PP; Antonucci R; Zaffanello M; Dessì A; Iacovidou N
    J Matern Fetal Neonatal Med; 2011 Oct; 24 Suppl 1():50-2. PubMed ID: 21942591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and renal tolerability of ibuprofen vs. indomethacin in preterm infants with patent ductus arteriosus.
    Fanos V; Benini D; Verlato G; Errico G; Cuzzolin L
    Fundam Clin Pharmacol; 2005 Apr; 19(2):187-93. PubMed ID: 15810899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of ibuprofen on bilirubin-albumin binding during the treatment of patent ductus arteriosus in preterm infant.
    Thibaut C; Hazard A; Huon C; Desfrere L
    J Matern Fetal Neonatal Med; 2011 Nov; 24 Suppl 3():7-9. PubMed ID: 21815876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of oral ibuprofen and intravenous indomethacin for closure of patent ductus arteriosus in preterm infants.
    Chotigeat U; Jirapapa K; Layangkool T
    J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S563-9. PubMed ID: 14700149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness and safety of indomethacin versus ibuprofen for the treatment of patent ductus arteriosus in preterm infants.
    Sivanandan S; Bali V; Soraisham AS; Harabor A; Kamaluddeen M
    Am J Perinatol; 2013 Oct; 30(9):745-50. PubMed ID: 23322388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ibuprofen and acute kidney injury in the newborn.
    Fanos V; Antonucci R; Zaffanello M
    Turk J Pediatr; 2010; 52(3):231-8. PubMed ID: 20718179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patent ductus arteriosus: wait and see?
    Schena F; Ciarmoli E; Mosca F
    J Matern Fetal Neonatal Med; 2011 Nov; 24 Suppl 3():2-4. PubMed ID: 21830997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological closure of patent ductus arteriosus: effects on pulse pressure and on endothelin-1 and vasopressin excretion.
    Zanardo V; Vedovato S; Chiozza L; Faggian D; Favaro F; Trevisanuto D
    Am J Perinatol; 2008 Jun; 25(6):353-8. PubMed ID: 18509786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-steroid anti-inflammatory drugs in the treatment of patent ductus arteriosus in European newborns.
    Guimarães H; Rocha G; Tomé T; Anatolitou F; Sarafidis K; Fanos V
    J Matern Fetal Neonatal Med; 2009; 22 Suppl 3():77-80. PubMed ID: 19925365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of patent ductus arteriosus: indomethacin or ibuprofen?
    Sekar KC; Corff KE
    J Perinatol; 2008 May; 28 Suppl 1():S60-2. PubMed ID: 18446180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus.
    Van Overmeire B; Smets K; Lecoutere D; Van de Broek H; Weyler J; Degroote K; Langhendries JP
    N Engl J Med; 2000 Sep; 343(10):674-81. PubMed ID: 10974130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of oral ibuprofen and indomethacin therapy for patent ductus arteriosus in preterm infants.
    Fakhraee SH; Badiee Z; Mojtahedzadeh S; Kazemian M; Kelishadi R
    Zhongguo Dang Dai Er Ke Za Zhi; 2007 Oct; 9(5):399-403. PubMed ID: 17937843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on management of patent ductus arteriosus in the preterm infant.
    Dani C
    J Matern Fetal Neonatal Med; 2011 Nov; 24 Suppl 3():1. PubMed ID: 21988761
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.